228 related articles for article (PubMed ID: 9079190)
1. The Gerhard Zbinden Memorial Lecture. Genetic polymorphism of drug metabolizing enzymes. Implications for toxicity of drugs and other xenobiotics.
Ingelman-Sundberg M
Arch Toxicol Suppl; 1997; 19():3-13. PubMed ID: 9079190
[No Abstract] [Full Text] [Related]
2. Pharmacogenetics of the cytochromes P450.
Daly AK
Curr Top Med Chem; 2004; 4(16):1733-44. PubMed ID: 15579105
[TBL] [Abstract][Full Text] [Related]
3. Cytochromes P450 and cancer.
Kaminsky LS; Spivack SD
Mol Aspects Med; 1999; 20(1-2):70-84, 137. PubMed ID: 10575653
[No Abstract] [Full Text] [Related]
4. Reactions and enzymes in the metabolism of drugs and other xenobiotics.
Testa B; Pedretti A; Vistoli G
Drug Discov Today; 2012 Jun; 17(11-12):549-60. PubMed ID: 22305937
[TBL] [Abstract][Full Text] [Related]
5. [Interindividual differences in efficacy and toxicity induced by therapeutic drugs and xenobiotics in relation to genetic polymorphisms in xenobiotic metabolizing enzymes].
Ozawa S
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):69-81. PubMed ID: 10097514
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism of cytochrome P450 and xenobiotic toxicity.
Ingelman-Sundberg M
Toxicology; 2002 Dec; 181-182():447-52. PubMed ID: 12505350
[TBL] [Abstract][Full Text] [Related]
7. Biotransformation of Drugs and other Xenobiotics as Key Modulator of Toxicity.
Orhan H
Curr Drug Metab; 2021; 22(8):582-583. PubMed ID: 34636292
[No Abstract] [Full Text] [Related]
8. [The biochemical basis of toxic actions of drugs and other xenobiotics].
Nuhn P
Pharm Unserer Zeit; 1993 Jul; 22(3):119-33. PubMed ID: 8367516
[No Abstract] [Full Text] [Related]
9. [The role of drug metabolizing enzymes in the effect and side-effect of the drugs].
Vereczkey L; Jemnitz K; Monostory K; Veres Z; Kóbori L
Orv Hetil; 2005 May; 146(19):947-52. PubMed ID: 15969306
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome P450s: mechanisms and biological implications in drug metabolism and its interaction with oxidative stress.
Bhattacharyya S; Sinha K; Sil PC
Curr Drug Metab; 2014; 15(7):719-42. PubMed ID: 25429675
[TBL] [Abstract][Full Text] [Related]
11. Update: genetic polymorphism of drug metabolizing enzymes in humans.
Tanaka E
J Clin Pharm Ther; 1999 Oct; 24(5):323-9. PubMed ID: 10583694
[TBL] [Abstract][Full Text] [Related]
12. [Toxicology and pharmacogenetics].
Dalhoff KP; Poulsen HE
Ugeskr Laeger; 2005 May; 167(20):2170-2. PubMed ID: 15987076
[No Abstract] [Full Text] [Related]
13. Genetic variability in susceptibility and response to toxicants.
Ingelman-Sundberg M
Toxicol Lett; 2001 Mar; 120(1-3):259-68. PubMed ID: 11323184
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic implications of polymorphisms in cytochromes and drug transporters].
Münster E; Ziegler S; Brunner M
Wien Med Wochenschr; 2005 Feb; 155(3-4):54-8. PubMed ID: 15791777
[TBL] [Abstract][Full Text] [Related]
15. Cytochromes P450, drugs, and diseases.
Guengerich FP
Mol Interv; 2003 Jun; 3(4):194-204. PubMed ID: 14993447
[No Abstract] [Full Text] [Related]
16. [Genetic polymorphism and risk of diseases induced by chemicals].
Zhang Z; Xia Z
Wei Sheng Yan Jiu; 2003 Jul; 32(4):402-5. PubMed ID: 14535113
[TBL] [Abstract][Full Text] [Related]
17. [What do we know about the drug metabolism?].
Pelkonen O; Raunio H
Duodecim; 1998; 114(10):971-7. PubMed ID: 11524785
[No Abstract] [Full Text] [Related]
18. How useful is the "cocktail approach" for evaluating human hepatic drug metabolizing capacity using cytochrome P450 phenotyping probes in vivo?
Tanaka E; Kurata N; Yasuhara H
J Clin Pharm Ther; 2003 Jun; 28(3):157-65. PubMed ID: 12795773
[TBL] [Abstract][Full Text] [Related]
19. Cytochrome P450 Induction and Xeno-Sensing Receptors Pregnane X Receptor, Constitutive Androstane Receptor, Aryl Hydrocarbon Receptor and Peroxisome Proliferator-Activated Receptor α at the Crossroads of Toxicokinetics and Toxicodynamics.
Hakkola J; Bernasconi C; Coecke S; Richert L; Andersson TB; Pelkonen O
Basic Clin Pharmacol Toxicol; 2018 Sep; 123 Suppl 5():42-50. PubMed ID: 29527807
[TBL] [Abstract][Full Text] [Related]
20. The impact of genetic polymorphisms in risk assessment of drugs.
Poulsen HE; Loft S
Arch Toxicol Suppl; 1994; 16():211-22. PubMed ID: 8192584
[No Abstract] [Full Text] [Related]
[Next] [New Search]
